Article Text

other Versions

PDF
Systematic review and meta-analysis
Ateplase for ischaemic stroke: increased risk of intracranial haemorrhage is balanced by improved stroke outcomes, particularly if treated within 3–4.5 h of onset
  1. Anthony Rudd
  1. Division Health and Social Care, Kings College London, London, UK
  1. Correspondence to : Professor Anthony Rudd, Division Health and Social Care, Kings College London, London se17eh, UK; anthony.rudd{at}kcl.ac.uk

Statistics from Altmetric.com

Commentary on: OpenUrlCrossRefPubMedWeb of Science

Implications for practice and research

  • Thrombolysis given to appropriate patients within 4.5 h of the onset of stroke symptoms increases the chance of a good outcome. The earlier it is given, the more likely it is to be effective.

  • Thrombolysis increases the risk of early death, but by 3–6 months mortality is equivalent in treated and untreated patients.

Context

The first major trial showing the benefit of alteplase for acute ischaemic stroke was published 20 years ago and involved …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.